English | Español

Pfizer
+ Community
Bree Gonzales | Mar 23, 2022

Pfizer and BioNTech request EUA for additional COVID-19 booster shots for people 65 and older
+ Technology/Innovation
Bree Gonzales | Feb 2, 2022

Molnupiravir is now the last choice for COVID-19: 'The Merck product is only 30% effective'
+ Technology/Innovation
Bree Gonzales | Aug 28, 2021

Pfizer’s is the first FDA-approved coronavirus vaccine, and now it has a name: Comirnaty
+ Regulatory
Harmony Valdoz | Aug 28, 2018

Pharmaceutical industry group backs proposal to share drug savings with Medicare beneficiaries
Press release submission | Apr 28, 2018

PFIZER: MYLOTARG™ Approved In The EU For The Treatment Of Previously Untreated, De Novo, CD33-positive Acute Myeloid Leukemia In Combination With Chemotherapy
Press release submission | Apr 28, 2018

PFIZER: Pfizer Provides Update on Proposed Trastuzumab Biosimilar
+ Technology/Innovation
Carol Ostrow | Jan 7, 2018

Merck, Pfizer Type 2 diabetes treatments gain FDA approval
+ Community
Carol Ostrow | Dec 26, 2017

Bristol-Myers Squibb, Pfizer, others aim to raise awareness of stroke risk in atrial fibrillation patients

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes